MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage

Journal of the Neurological Sciences

Volumn 251, Issue 1-2, 2006, Pages 82-86

  Horstmann, Solveig ^a   Su, Ying ^a   Koziol, James ^b   Meyding Lamadé, Uta ^a   Nagel, Simon ^a   Wagner, Simone ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Metalloproteinases; Peripheral blood; Reliability; Reproducibility; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B;

ADULT; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STROKE; SUBARACHNOID HEMORRHAGE; ZYMOGRAPHY;

ADULT; AGED; AREA UNDER CURVE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; REFERENCE VALUES; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 33751249568     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.09.005     Document Type: Article

References (20)

1. Dorsch N.W. Cerebral arterial spasm a clinical review. Br J Neurosurg 9 (1995) 403-412
2. Montaner J., Alvarez-Sabin J., Molina C.A., Angles A., Abilleira S., Arenillas J.F., et al. Matrix metalloproteinase expression after human cardioembolic stroke. Stroke 32 (2001) 1759-1766
3. Horstmann S., Kalb P., Koziol J., Gardner H., and Wagner S. Profiles of metalloproteinases, their inhibitors, and Laminin in stroke patients influence of different therapies. Stroke 34 9 (2003) 2165-2170
4. Alvarez-Sabin J., Delgado P., Abilleira S., Molina C.A., Arenillas J., Ribo M., et al. Temporal profile of metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage. Stroke 35 (2004) 1316-1322
5. Todor D.R., Lewis I., Bruno G., and Chyatte D. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. Stroke 29 8 (1998) 1580-1583
6. Bruno G., Todor R., Lewis I., and Chyatte D. Vascular extracellular matrix remodelling in cerebral aneurysms. J Neurosurg 89 3 (1998) 431-440
7. Lindholt J.S., Vammen S., Fasting H., Henneberg E.W., and Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 20 (2000) 281-285
8. Hunt W.E., and Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28 (1968) 14-20
9. Bland J.L., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) i:307-i:310
10. Murphy G. Matrix metalloproteinases and their inhibitors. Acta Orthop Scand Suppl 266 (1995) 55-60
11. Gaetani P., Rodriguez Y., Baena R., Tartara F., Massina A.L., Tancioni F., et al. Metalloproteinases and intracranial lesions. Neurol Res 21 4 (1999) 385-390
12. Sehba F.A., Mostafa G., Knopman J., Friedrich V., and Bederson J.B. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg 101 (2004) 633-640
13. Wagner S., Tagaya M., Koziol J.A., Quaranta V., and del Zoppo G.J. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/reperfusion. Stroke 28 4 (1997) 858-865
14. Li Z., Li L., Zielke H.R., Cheng L., Xiao R., Crox M.T., et al. Increased expression of 72-kD type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 148 (1996) 121-128
15. Galis Z.S., Sukhova G.K., Kranzhofer R., Clark S., and Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 92 (1995) 402-406
16. Romanic A.M., and Madri J.A. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 125 (1994) 1165-1178
17. Menashi S., Lu H., Soria C., and Legrand Y. Endothelial cell proteases: physiological role and regulation. Bailliere's Clin Haematol 6 (1993) 559-576
18. Galis Z.N., Kranzhofer R., Fenton II J.W., and Libby P. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17 (1997) 483-489
19. Kim S.C., Singh M., Huang J., Prestigiacomo C.J., Winfree C.J., Solomon R.A., et al. Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurg 41 3 (1997) 642-666
20. McGirt M.J., Lynch J.R., Blessing R., Warner D.S., Friedmann A.H., and Laskowitz DT. Serum von Willebrand Factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg 51 5 (2002) 1128-1135